| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/17/2013 | WO2013009545A1 Engineered polypeptides having enhanced duration of action with reduced immunogenicity |
| 01/17/2013 | WO2013009018A1 Novel esterase derived from compost metagenome, and production method therefor |
| 01/17/2013 | WO2012161956A3 High-purity production of multi-subunit proteins such as antibodies in transformed microbes such as pichia pastoris |
| 01/17/2013 | WO2012061558A3 Dual variable domain immunoglobulins and uses thereof |
| 01/17/2013 | US20130018177 Production of Sialylated N-Glycans in Lower Eukaryotes |
| 01/17/2013 | US20130018176 Methods of producing hybridomas and monoclonal antibodies and antibodies produced thereby |
| 01/17/2013 | US20130018175 Single variable domain antibodies against ox40l, constructs and therapeutic use |
| 01/17/2013 | US20130018174 Polypeptide modification method for purifying polypeptide multimers |
| 01/17/2013 | US20130017996 Muteins of tear lipocalin and methods for obtaining the same |
| 01/17/2013 | US20130017577 Methods for enhanced protein production |
| 01/17/2013 | US20130017576 Method for the production of proteins and peptides |
| 01/17/2013 | US20130017575 Nucleic acids encoding anti-IL-6 antibodies of defined epitopic specificity |
| 01/17/2013 | US20130017574 Methods and compositions for enhanced expression and secretion of proteins |
| 01/17/2013 | US20130017573 Preparation of protective antigen |
| 01/17/2013 | US20130017572 Codon modified polynucleotide sequences for enhanced expression in a host system |
| 01/17/2013 | US20130017201 Bispecific monoclonal antibody capable of cross reacting with lethal factor (lf) and edema factor (ef), and neutralizing edema toxin (et) as well as lethal toxin (lt) of bacillus anthracis |
| 01/17/2013 | US20130017193 Antibody formulations |
| 01/17/2013 | CA2841470A1 Methods and compositions for consumables |
| 01/17/2013 | CA2840951A1 Method for purifying fc-fusion protein |
| 01/16/2013 | EP2546347A2 Glycoprotein composition from engineered galactose assimilation pathway in Pichia pastoris |
| 01/16/2013 | EP2546342A1 Method for selecting polypeptide sequence, metal oxide or silicon containing compound binding peptide and use thereof |
| 01/16/2013 | EP2546341A1 Fc binding protein and method for producing same |
| 01/16/2013 | EP2546340A1 High expression promoter derived from kluyveromyces marxianus |
| 01/16/2013 | EP2546265A1 Eukaryotic cell-free protein expression system especially suitable for disulfide-bridges comprising proteins |
| 01/16/2013 | CN1495197B G-CSF analogs composition and its preparation method |
| 01/16/2013 | CN1454257B Production of recombinant blood clotting factors in human cell lines |
| 01/16/2013 | CN102883596A Aboveground organ specific promoters for transforming plants and uses thereof |
| 01/16/2013 | CN102876765A Method for preparing antioxidant peptide with waste tea leaves |
| 01/16/2013 | CN102876764A Preparation method of yak milk casein antibacterial peptide |
| 01/16/2013 | CN102876763A Method for comprehensively utilizing waste residues and liquid waste of animal biochemical products |
| 01/16/2013 | CN102876762A Processing technology for extracting protein by broken rice enzyme method |
| 01/16/2013 | CN102876761A Production of tnfr-ig |
| 01/16/2013 | CN102876682A Schistosoma Japonicum polymorphism antigen gene and application thereof as vaccine |
| 01/16/2013 | CN102875683A Fc fusion protein of long-acting recombinant human growth hormone |
| 01/16/2013 | CN102875680A Anti-CD33 antibodies and method for treatment of acute myeloid leukemia using the same |
| 01/16/2013 | CN102875679A Anti-platelet membrane glycoprotein vi monoclonal antibody |
| 01/16/2013 | CN102875677A Humanized anti-egfl7 antibodies and methods using same |
| 01/16/2013 | CN102875674A Anti-tetanotoxin antibody, and preparation method and application thereof |
| 01/16/2013 | CN102318724B Production method of acid soybean peptide protein |
| 01/16/2013 | CN102168124B Method for preparing wheat germ active polypeptide by composite enzyme and alkaline combination method |
| 01/16/2013 | CN101974588B Method for preparing fish collagens |
| 01/16/2013 | CN101948543B Fusion protein and coding gene and application thereof |
| 01/16/2013 | CN101928346B Monoclonal antibody of anti-human tissue kallikrein and preparation method thereof |
| 01/16/2013 | CN101294164B Expression of recombinant human metaphase factor (rh-Midkine), preparation and application of monoclone antibody |
| 01/16/2013 | CN101095053B Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84 |
| 01/16/2013 | CN101090969B Rhamnose promoter expression system and uses thereof |
| 01/15/2013 | US8354518 HCV replicons containing NS5B from genotype 2B |
| 01/15/2013 | US8354517 Thermophilic and thermoacidophilic sugar transporter genes and enzymes from Alicyclobacillus acidocaldarius and related organisms, methods |
| 01/15/2013 | US8354508 PRO115 antibody compositions and methods of use |
| 01/15/2013 | US8354378 G protein coupled receptor antagonists and methods of activating and inhibiting G protein coupled receptors using the same |
| 01/15/2013 | US8354268 Protein glycosylation modification in methylotrophic yeast |
| 01/15/2013 | US8354263 Family 44 xyloglucanases |
| 01/15/2013 | US8354251 Transactivation system for mammalian cells |
| 01/15/2013 | US8354249 Intravenous immunoglobulin composition |
| 01/15/2013 | US8354248 Promoter-encoding DNA fragment, recombinant vector, recombiant transformant, and uses thereof |
| 01/15/2013 | US8354247 Glycoprotein synthesis and remodeling by enzymatic transglycosylation |
| 01/15/2013 | US8354240 VMP-like sequences of pathogenic Borrelia |
| 01/15/2013 | US8354105 Methods for modulating mannose content of recombinant proteins |
| 01/15/2013 | CA2475929C Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries |
| 01/15/2013 | CA2409031C Insecticidal secreted proteins of brevibacillus laterosporus |
| 01/15/2013 | CA2406725C Edg8 receptor, its preparation and use |
| 01/15/2013 | CA2400842C Novel compounds |
| 01/10/2013 | WO2013006479A2 Mammalian cell culture |
| 01/10/2013 | WO2013006244A1 Bispecific monoclonal antibody therapeutics against west nile virus with improved cns penetration |
| 01/10/2013 | WO2013005649A1 Anti-human ccr6 antibody |
| 01/10/2013 | WO2013004076A1 Agr2 blocking antibody and use thereof |
| 01/10/2013 | WO2012118780A3 Preparation of peptide mixtures by protease catalysis designed to provide useful biological and physical properties |
| 01/10/2013 | US20130012690 Method for stabilization of proteins using non-natural amino acids |
| 01/10/2013 | US20130012687 Inducible self-cleaving protease tag and method of purifying recombinant proteins using the same |
| 01/10/2013 | US20130012446 Compositions and manufacture of mammalian stem cell-based cosmetics |
| 01/10/2013 | US20130012437 Lytic peptides having anti-proliferative activity against prostate cancer cells |
| 01/10/2013 | US20130011878 Antigen binding proteins that bind par-2 |
| 01/10/2013 | US20130011877 Kex2 cleavage regions of recombinant fusion proteins |
| 01/10/2013 | US20130011876 Process for preparing filamentous fungal strains having a sexual cycle and a process for preparing sexually crossed filamentous fungal strains |
| 01/10/2013 | US20130011875 Methods for the production of recombinant proteins with improved secretion efficiencies |
| 01/10/2013 | US20130011874 Reduced genome e. coli |
| 01/10/2013 | US20130011873 Enzyme that catalyzes a peptide-forming reaction from a carboxy component and an amine component, microbe producing the same, and a method of producing a dipeptide using the enzyme or microbe |
| 01/10/2013 | US20130011428 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
| 01/10/2013 | US20130011425 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 01/10/2013 | US20130011418 Antibody-Drug Conjugates |
| 01/10/2013 | US20130011412 Antibodies to lymphotoxin-alpha |
| 01/10/2013 | US20130011402 Compositions and methods for the diagnosis and treatment of tumor |
| 01/10/2013 | US20130011401 Soluble proteins for use as therapeutics |
| 01/10/2013 | US20130011394 Complexes comprising mhc class i fusion polypeptides and antigen-specific antibodies and methods of use |
| 01/10/2013 | US20130011389 Compositions and methods for treating coagulation related disorders |
| 01/10/2013 | US20130011382 Fibrinogen Preparations Enriched In Fibrinogen With An Extended Alpha Chain |
| 01/10/2013 | CA2841372A1 Agr2 blocking antibody and use thereof |
| 01/10/2013 | CA2838695A1 Mammalian cell culture |
| 01/09/2013 | EP2543728A1 Process for production of useful substance using genetically modified streptomyces ray fungus |
| 01/09/2013 | EP2543727A1 Modified antibody composition |
| 01/09/2013 | EP2542574A2 Method for producing soluble recombinant interferon protein without denaturing |
| 01/09/2013 | CN102869784A High mannose glycans |
| 01/09/2013 | CN102864201A Preparation method of corn active peptides |
| 01/09/2013 | CN102864200A Method for preparing ACE (Angiotensin Converting Enzyme) inhibitory peptide by hydrolyzing rice protein isolate with complex enzyme |
| 01/09/2013 | CN102864199A Method for producing anti-oxidative polypeptide by using rice residue |
| 01/09/2013 | CN102864198A Recombinant human proinsulin transpeptidation method and application in recombinant human proinsulin downstream purification thereof |
| 01/09/2013 | CN102864197A Method for producing low-molecular weight collagen peptide by utilizing leftovers left by processing prawns |
| 01/09/2013 | CN102864196A Method for preparing alpha-small aspartyl-peptide by means of dihydroorotase |
| 01/09/2013 | CN102864114A Strain for highly yielding enramycin, and preparation method and application thereof |
| 01/09/2013 | CN102863531A CD20-resistant monoclonal antibody as well as preparation method and application thereof |